Insider Transactions in Q3 2022 at Horizon Therapeutics Public LTD CO (HZNP)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price | 
|---|---|---|---|---|---|
| 
            Aug 04                          
            2022                          
           | Sean M. Clayton EVP, General Counsel | 
              BUY
             
                Open market or private purchase
             | Indirect | 
              745
              +50.0%
           | 
              $49,170              
              $66.67 P/Share              
           | 
| 
            Jul 29                          
            2022                          
           | Andy Pasternak EVP, Chief Strategy Officer | 
              SELL
             
                Open market or private sale
             | Direct | 
              4,850
              -6.33%
           | 
              $397,700              
              $82.95 P/Share              
           | 
| 
            Jul 20                          
            2022                          
           | Elizabeth H.Z. Thompson EVP, Research & Development | 
              SELL
             
                Open market or private sale
             | Direct | 
              5,917
              -45.92%
           | 
              $502,945              
              $85.0 P/Share              
           | 
| 
            Jul 19                          
            2022                          
           | Elizabeth H.Z. Thompson EVP, Research & Development | 
              SELL
             
                Open market or private sale
             | Direct | 
              90
              -0.35%
           | 
              $7,650              
              $85.03 P/Share              
           | 
| 
            Jul 07                          
            2022                          
           | Elizabeth H.Z. Thompson EVP, Research & Development | 
              SELL
             
                Open market or private sale
             | Direct | 
              82
              -0.63%
           | 
              $6,970              
              $85.01 P/Share              
           |